SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,805 | -46.0% | 12,195 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $20,000 | -85.0% | 12,195 | -29.9% | 0.00% | -75.0% |
| Q3 2021 | $133,000 | -35.7% | 17,400 | -18.4% | 0.00% | -42.9% |
| Q2 2021 | $207,000 | -30.8% | 21,318 | -40.9% | 0.01% | -36.4% |
| Q1 2021 | $299,000 | +8.3% | 36,068 | -10.5% | 0.01% | -26.7% |
| Q4 2020 | $276,000 | -9.2% | 40,306 | +47.2% | 0.02% | -6.2% |
| Q3 2020 | $304,000 | +38.2% | 27,387 | -21.6% | 0.02% | +6.7% |
| Q2 2020 | $220,000 | – | 34,926 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |